By Nsunjo Erica
According to data compiled by Johns Hopkins University, the global tally for confirmed cases of the COVID-19 virus has surpassed 18.5 million as of Wednesday.
According to Johns Hopkins University compiled data, At least 11.6 million people have recovered from the COVID-19 virus.
The US accounted for the world’s highest number of infections and fatalities at 4,665,932 and 154,841, respectively, according to the CSSE released data.
According to CSSE compiled COVID-19 data, Brazil came in second place with 2,733,677 infections and 94,104 deaths from the infection.
China where the illness was first reported late last year, has 88,206 cases, and 4,676 fatalities. The U.K. has 307,256 cases and 46,295 fatalities, the highest in Europe.
As of the beginning of this week, the total number of cases stood at 18,002,567 and the recoveries rose to 11.2 Million, the University’s Center for Systems Science and Engineering (CSSE) revealed in its latest update.
In terms of cases, India ranks third (1,750,723), and is followed by Russia (849,277) then South Africa (511,485), Mexico (439,046), Peru (422,183), Chile (359,731), Iran (309,437), the UK (307,256), Colombia (306,181).
Following is Spain (288,522), Pakistan (279,699), Saudi Arabia (278,835), Italy (248,070), Bangladesh (240,746), Turkey (232,856), France (225,198), Germany (211,220), Argentina (201,919), Iraq (129,151), and Canada (118,768).
Coming next is Indonesia (111,455), Qatar (111,107), and the Philippines (103,185), the CSSE figures showed.
Current News On COVID-19 Vaccines
According to the World Health Organization, there are at least 21 vaccines currently under trial worldwide whereby every country and every lab is taking a different approach to finding the right solution to stop COVID-19.
US researchers reported that the first COVID-19 vaccine tested boosted up people’s immune systems just the way scientists had hoped and that the shots are poised to begin key final testing.
Russia also recently just completed its first COVID-19 vaccine trials on humans and it proved that the vaccine is safe, however, there was no other information on when this vaccine would enter commercial production.